The histopathology of fatal untreated human respiratory syncytial virus infection

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Modern Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.3800725PMID 17143259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals.

  2006cited by this paper
• Replication-Dependent Potent IFN-α Induction in Human Plasmacytoid Dendritic Cells by a Single-Stranded RNA Virus1

  2004cited by this paper
• Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells

  2003cited by this paper
• Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis.

  2002cited by this paper
• Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology

  2002cited by this paper
• NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus

  2002cited by this paper
• Leucocyte populations in respiratory syncytial virus‐induced bronchiolitis

  2001cited by this paper
• Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection.

  2001cited by this paper
• Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

  2000cited by this paper
• Respiratory syncytial virus-induced chronic bronchiolitis in experimentally infected calves

  2000cited by this paper
• Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials.

  1997cited by this paper
• Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus

  1997cited by this paper
• Interactions of viruses with respiratory epithelial cells

  1996cited by this paper
• Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves

  1995cited by this paper
• Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

  1994cited by this paper
• Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

  1991cited by this paper
• Pulmonary epithelial T cells induced by viral infection express T cell receptors α/β

  1991cited by this paper
• Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

  1990cited by this paper
• Demonstration of respiratory syncytial virus in an autopsy series.

  1990cited by this paper
• Fatal respiratory syncytial virus pneumonitis in a previously healthy child.

  1989cited by this paper
• Primary respiratory syncytial virus infection in mice

  1988cited by this paper
• Fatal respiratory syncytial virus pneumonitis in a previously healthy child.

  1988cited by this paper
• Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

  1986cited by this paper
• Cellular Pathology Technique

  1986cited by this paper
• Role of respiratory viruses in childhood mortality.

  1975cited by this paper
• Sudden and Unexpected Deaths in Infants: Histology and Virology

  1973cited by this paper
• Pathological changes in virus infections of the lower respiratory tract in children

  1970cited by this paper
• Deaths associated with respiratory tract infection in childhood.

  1967cited by this paper
• IMMUNOFLUORESCENT EVIDENCE OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CASES OF GIANT CELL BRONCHIOLITIS IN CHILDREN.

  1965cited by this paper
• Virus Pneumonia of Infants Secondary to Epidemic Infections.

  1939cited by this paper

• B cells and iBALT in TB immunity & pathogenesis.

  2026cites this paper
• Differential antiviral effects and immune responses in nasal and airway organoid during RSV infection: implications for interferon therapy.

  2026cites this paper
• The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis

  2026cites this paper
• STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation

  2026influential citation
• Bacterial isolates, antibiotic susceptibility, and determinants of positive blood culture in children with community-acquired pneumonia in Central Tanzania

  2025cites this paper
• Compound screening in human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies

  2025cites this paper
• Influenza Virus: Genomic Insights, Evolution, and its Clinical Presentation.

  2025cites this paper
• Cotton Rat Model of Respiratory Syncytial Virus Infection.

  2025cites this paper
• Utilizing Neonatal Tracheal Aspirate-Derived Bronchial Basal Stem Cells to Model Respiratory Syncytial Virus Infection.

  2025cites this paper
• Bovine Model of Respiratory Syncytial Virus Infection.

  2025cites this paper
• Molecular Mechanisms of Respiratory Syncytial Virus Pathogenesis.

  2025cites this paper
• Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection

  2025cites this paper
• Development and Validation of a Temporal Progression-based Risk Assessment Tool for Respiratory Syncytial Virus Infection in Infants

  2025cites this paper
• Macrophages Mediate Antiviral Immunity and Repair of Type 2 Alveolar Epithelial Cells in a Human Stem Cell Model

  2025cites this paper
• Respiratory syncytial virus (RSV): prevention and antiviral therapeutic strategies

  2025cites this paper
• Autopsy-related histomorphological findings in neonatal sepsis: a narrative review

  2025cites this paper
• The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.

  2025cites this paper
• Update on vaccines against respiratory syncytial virus (RSV): A narrative review.

  2025cites this paper
• Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical Implications

  2025cites this paper
• Neutrophilic and eosinophilic inflammation in bronchiolitis and long-term respiratory sequelae.

  2025cites this paper
• Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention

  2025cites this paper
• Introduction to Respiratory Syncytial Virus.

  2025cites this paper
• Interactions between epithelial mesenchymal plasticity, barrier dysfunction and innate immune pathways shape the genesis of allergic airway disease

  2025cites this paper
• Three-dimensional cell culture models in respiratory virus research: technological advances and current applications.

  2025cites this paper
• Evaluation of the effect of inhaled β2 agonist on lung sounds of children with acute bronchiolitis

  2025cites this paper
• Deciphering the Role of Macrophages in RSV Infection and Disease

  2025cites this paper
• Integrated Approach to Pediatric bronchiolitis Control: Role of Respiratory Professionals, Nursing Care, Imaging Support, Primary Care, Pharmacotherapy, and Public Health Surveillance

  2025cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals

  2025cites this paper
• Rapid generation of a murine RSV infectious model by transducing a conditional knock-in mouse harboring human IGF1 receptor with adenoviral vector.

  2025cites this paper
• Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections.

  2025cites this paper
• Applications of human lung organoids to human respiratory virus research: advances, limitations and future directions

  2025cites this paper
• Crucial Obstacles and Strategies for Human RSV Pediatric Vaccine Development

  2025cites this paper
• Role of Respiratory Viruses in Severe Acute Respiratory Failure

  2025cites this paper
• B-Raf kinase blockade protects airway epithelial cells against respiratory syncytial virus infection and modulates interferon responses

  2025cites this paper
• Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants

  2025cites this paper
• Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus

  2024cites this paper
• The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease

  2024cites this paper
• Surfactant Protein-A (SP-A) and its Immunomodulatory Roles in Infant Respiratory Syncytial Virus (RSV) Infection - a potential for therapeutic intervention?

  2024cites this paper
• Transcriptome profiling of macrophages persistently infected with human respiratory syncytial virus and effect of recombinant Taenia solium calreticulin on immune-related genes

  2024cites this paper
• Landscape of respiratory syncytial virus

  2024cites this paper
• Imaging in pulmonary infections of immunocompetent adult patients

  2024cites this paper
• Development of innate and adaptive immunity to RSV in young children.

  2024cites this paper
• An altered natural killer cell immunophenotype characterizes clinically severe pediatric RSV infection

  2024cites this paper
• Comparative Efficacy of Nebulized Salbutamol with Single-Dose Parenteral Dexamethasone Versus Nebulized Salbutamol Alone in Infants with Acute Bronchiolitis: A Randomized Control Trial

  2024cites this paper
• Cooperative interaction of interferon regulatory factor -1 and bromodomain—containing protein 4 on RNA polymerase activation for intrinsic innate immunity

  2024cites this paper
• Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children

  2024cites this paper
• Respiratory syncytial virus subtypes in children with bronchiolitis: does it correlate with clinical severity?

  2024cites this paper
• Potential co-infection of influenza A, influenza B, respiratory syncytial virus, and Chlamydia pneumoniae: a case report with literature review

  2024cites this paper
• Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses

  2024cites this paper
• ATP-P2X7R pathway activation limits the Tfh cell compartment during pediatric RSV infection

  2024cites this paper
• Compound screening in primary human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies

  2024cites this paper
• RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia.

  2024cites this paper
• Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers.

  2023cites this paper
• Use of a human small airway epithelial cell line to study the interactions of Aspergillus fumigatus with pulmonary epithelial cells

  2023cites this paper
• Human T cells efficiently control RSV infection

  2023cites this paper
• Metatranscriptome Reveals Specific Immune and Microbial Signatures of Respiratory Syncytial Virus Infection in Children

  2023cites this paper
• Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators

  2023cites this paper
• The Maresin 1–LGR6 axis decreases respiratory syncytial virus-induced lung inflammation

  2023cites this paper
• Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

  2023cites this paper
• Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications

  2023cites this paper
• Respiratory Syncytial Virus Infection: An Update

  2023cites this paper
• Outcomes of corticosteroid treatment in critical Ill adult patients with respiratory viruses-related community acquired pneumonia - a propensity-matched case control study.

  2023cites this paper
• Host–Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans

  2023cites this paper
• Use of a human small airway epithelial cell line to study the interactions of Aspergillus fumigatus with pulmonary epithelial cells

  2023cites this paper
• Respiratory Syncytial Virus Infections in Neonates: A Persisting Problem

  2023cites this paper
• Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants

  2023cites this paper
• Pathogenicity and virulence of human respiratory syncytial virus: Multifunctional nonstructural proteins NS1 and NS2

  2023cites this paper
• SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication

  2023cites this paper
• Age-related STAT3 signaling regulates severity of respiratory syncytial viral infection in human bronchial epithelial cells

  2023cites this paper
• Role of epithelial barrier function in inducing type 2 immunity following early‐life viral infection

  2023cites this paper
• Neutrophil responses to RSV infection show differences between infant and adult neutrophils

  2023cites this paper
• Clinical application of a lung sound analysis in infants with respiratory syncytial virus acute bronchiolitis

  2023cites this paper
• Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now?

  2023cites this paper
• Respiratory syncytial virus: an overview

  2023cites this paper
• RSV replication modifies the XBP1s binding complex on the IRF1 upstream enhancer to potentiate the mucosal anti-viral response

  2023cites this paper
• The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections

  2023cites this paper
• Propagation of human respiratory syncytial virus in cells derived from the black flying fox (Pteropus alecto)

  2023cites this paper
• Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022)

  2023cites this paper
• Respiratory syncytial virus infection and novel interventions

  2023cites this paper
• Immunological Response to Respiratory Syncytial Virus Infection

  2023cites this paper
• Vitamin D3 protects against respiratory syncytial virus-induced barrier dysfunction in airway epithelial cells via PKA signaling pathway

  2023cites this paper
• Innate Immunity, Epithelial Plasticity, and Remodeling in Asthma.

  2023cites this paper
• Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children

  2023cites this paper
• Bioengineered Co-culture of organoids to recapitulate host-microbe interactions

  2022cites this paper
• Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review

  2022cites this paper
• RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

  2022cites this paper
• Doğal Solunum Sinsitiyal Virüsü (RSV) ile Enfekte Koyun ve Keçi Akciğer Parafin Bloklarında TNF-a Ekspresyonunun İmmünohistokimyasal Olarak İncelenmesi

  2022cites this paper
• Factors Limiting the Translatability of Rodent Model–Based Intranasal Vaccine Research to Humans

  2022cites this paper
• IFN-λ Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase–Induced PAD4-Independent NETosis

  2022cites this paper
• Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy

  2022cites this paper
• Physiology and Pathophysiology of Human Airway Mucus.

  2022cites this paper
• Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation

  2022cites this paper
• Validating a bovine model for lung ultrasound of bronchiolitis

  2022cites this paper
• Development of mRNA vaccines against respiratory syncytial virus (RSV).

  2022cites this paper
• An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma

  2022influential citation
• Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection

  2022cites this paper
• Cilia-related gene signature in the nasal mucosa correlates with disease severity and outcomes in critical respiratory syncytial virus bronchiolitis

  2022cites this paper
• Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles

  2022cites this paper
• Integrated relationship of nasopharyngeal airway host response and microbiome associates with bronchiolitis severity

  2022cites this paper
• CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns

  2022cites this paper